Back to search

Article

Remdesivir is a Delayed Translocation Inhibitor of SARS CoV-2 Replication

2020-12-15

Abstract excerpt

Remdesivir is a nucleoside analog approved by the FDA for treatment of COVID-19. Here, we present a 3.9-Å-resolution cryoEM reconstruction of a remdesivir-stalled RNA-dependent RNA polymerase complex, revealing full incorporation of three copies of remdesivir monophosphate (RMP) and a partially incorporated fourth RMP in the active site. The structure reveals that RMP blocks RNA translocation after incorporatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0154a301-3186-5e0b-8f11-73f737980717
DOI
10.2139/ssrn.3749649
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Remdesivir is a Delayed Translocation Inhibitor of SARS CoV-2 ReplicationDOI 10.2139/ssrn.3749649
Select a neighboring publication to make it the new centre.